IRS1 and hepatocellular carcinoma: The downregulation of PYCR1 dramatically repressed cell growth and survival by inactivating the c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathway in hepatocellular cancer cells [28].